Publicly listed pharmaceutical company PT Kalbe Farma says that it is expecting sales to increase by up to 18 percent this year.
“Around 15 to 18 percent growth is average in our business. It is likely that the nutritional division will report higher growth,” Kalbe Farma finance director and corporate secretary Vidjongtius said here on Sunday.
Kalbe Farma’s prescription drug, consumer health, nutrition and distribution and logistics division all contributed equally to the company’s total sales in 2012, according to Vidjongtius.
The company established last year PT Kalbe Milko Indonesia, a joint venture that has been planning to build nutritional drink production facility.
Vidjongtius said that the company’s business grew in line with expectations for 2012, estimating that Kalbe Farma would record a sales increase of 24 to 25 percent in 2012 compared to the previous year.
Although the firm has not issued figures for its full-year financial performance last year, a 25 percent increase over the firm’s Rp 10.91 trillion (US$1.13 billion) booked in net sales in 2011 would be about Rp 13 trillion.
Extrapolating further, the firm’s 18 percent estimate for sales growth for 2013 might translate into almost Rp 15 trillion.
Sales growth in 2012 was supported by, among other things, distribution from a new principal, PT Abbot Indonesia, that boosted the contribution of the distribution division to Kalbe’s total income,
Vidjongtius added.
Kalbe’s distribution business is run by 91.75 percent owned subsidiary PT Enseval Putra Megatrading, which is also listed on the Indonesia Stock Exchange.
“This year, we don’t see a new principal cooperating with us. Therefore, this year’s growth rate will be lower than last year. However, our growth is still above the market average,” Vidjongtius said.
The firm’s pharmaceuticals division would likely book 12 to 15 percent sales growth this year, according to Kalbe Farma.
Vidjongtius said that new health products, such its Hydro Coco health drink, Tipco juice products and other newly acquired products contributed the most to the company’s growth last year.
Last year, the company acquired PT Hale International, the producer of Original Love Juice health drink and Pome Rama.
Vidjongtius said that Kalbe would continue to study additional acquisitions for 2013.
“We keep doing studies to investigate the possibility of acquisitions for Indonesia and the Southeast Asia region,” Vidjongtius said.
“However, it’s difficult to predict realization. Acquisition is our secondary strategy and we are keeping the focus on developing existing business,” he added.
No comments:
Post a Comment